The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits
Journal of Applied Toxicology August 30, 2023 Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet et al. 2 citations
Abstract Serotonergic psychedelics, such as lysergic acid diethylamide (LSD), psilocybin, dimethyltryptamine (DMT), and 5‐methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT), are currently being investigated for the treatment of psychiatric disorders such as depression and anxiety. Clinical trials with psilocybin and LSD have shown improvement in emotional and psychological scores. Although these...